Skip to Content

'
Robert A. Wolff, M.D.

Present Title & Affiliation

N/A

Office Address

The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Boulevard
Unit Number: 421
Houston, TX 77030
Room Number: FC11.2018
Phone: (713) 745-5476
Fax: (713) 794-1807

Education & Training

Degree-Granting Education

1986 Albany Medical College, Albany, NY, MD
1979 Colgate University, Hamilton, NY, BA, Mathematical Economics

Postgraduate Training

7/1989-6/1992 Fellowship Training Hematology/Oncology, Division of Hematology/Oncology Department of Medicine Duke University Medical Center, Durham, NC
6/1986-6/1989 Clinical Residency, Internal Medicine, Department of Medicine, Duke University Medical Center, Durham, NC
6/1983-9/1984 NIH-Summer Student Fellowship Biochemistry/Protein Purification, Department of Biochemistry Albany Medical College, Albany, NY, James Dias, Ph.D.
1/1981-7/1982 Graduate Studies In vitro fertilization/Reproductive Physiology Barry Zirkin, Ph.D., Division of Reproductive Biology Department of Population Dynamics The Johns Hopkins School of Hygiene and Public Health, Baltimore, MD, Barry Zirkin, Ph.D.

Board Certifications

1/1989 Internal Medicine

Selected Publications

Peer-Reviewed Original Research Articles
1. Heaton NS, Wolff RA, Malinowski RL, Hullett DA, Hoch JR. Antisense to Transforming Growth Factor-beta(1) Facilitates the Apoptosis of Macrophages in Rat Vein Grafts. J Vasc Res 45(5):365-374, Sep-Oct, 3/2008. PMID: 18354256.
2. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5). e-Pub 3/2008. PMID: 18471707.
3. Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of Locoregional Recurrence After Surgery and Radiotherapy or Chemoradiation for Rectal Cancer. Int J Radiat Oncol Biol Phys 71(4):1175-80, 1/2008. e-Pub 1/2008. PMID: 18207667.
4. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-707, Sep-Oct, 12/2007. PMID: 17764494.
5. Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C. Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 34(3):244-52, May-Jun, 9/2007. PMID: 17513082.
6. Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA. Future chemoradiation strategies in pancreatic cancer. Semin Oncol 34(4):335-46, May-Jun, 8/2007. PMID: 17674962.
7. Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 110(1):47-55, May-Jun, 7/1/2007. PMID: 17538975.
8. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52-60, May-Jun, 7/2007. PMID: 17592291.
9. Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer 109(12):2547-56, May-Jun, 6/15/2007. PMID: 17492688.
10. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W, Parulekar W. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25(15):1960-6, May-Jun, 5/20/2007. PMID: 17452677.
11. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109(9):1750-5, 5/1/2007. PMID: 17387743.
12. Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging, May-Jun, 5/24/2007. PMID: 17522753.
13. Li D, Li Y, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Effects of base excision repair gene polymorphisms on pancreatic cancer survival. Int J Cancer 120(8):1748-54, 4/2007. PMID: 17230526.
14. Aloia TE, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg 204(3):347-55, 3/2007. PMID: 17324767.
15. Bedi M, Das P, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Wolff RA, Janjan NA, Drishnan S, Crane CH. Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer. Gastrointestinal Cancer Research 1:44-48, 2007.

Last updated: 9/21/2009